Voyager Therapeutics
VYGR
35 hedge funds and large institutions have $225M invested in Voyager Therapeutics in 2015 Q4 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$89.9M |
| 2 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$35.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$33.9M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$20.7M |
| 5 |
Goldman Sachs
New York
|
+$18.8M |
Top Sellers
VYGR Hedge Fund Activity: Q4 2015 in Review
35 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2015, worth a combined $225M.
Buyers outnumbered sellers: 35 funds opened new VYGR positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $89.9M.
- 35 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $225M of Voyager Therapeutics stock for Q4 2015.
- 35 funds opened new Voyager Therapeutics positions in Q4 2015 and 0 closed out, a net change of +35 holders.
- The largest Voyager Therapeutics buyer in Q4 2015 was Fidelity Investments, an estimated $89.9M added.
Based on aggregated 13F filings for Q4 2015.